Intranasal corticosteroids and allergic rhinoconjunctivitis
Authors:
- Leonard BieloryLBLeonard Bielory
- 1 October 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 8 (5) , 450-456
Abstract
To describe recent insight into the efficacy of intranasal corticosteroids in treating ocular signs and symptoms of allergic rhinoconjunctivitis. The efficacy of intranasal corticosteroids in treating allergic nasal symptoms is well established, and recent evidence indicates that this class of medication may be effective at alleviating ocular symptoms as well. The present review reveals that the method of scoring ocular symptoms in a clinical trial may influence whether statistically significant improvements are detected among patients using intranasal corticosteroids. Improvement is more likely to be detected if symptoms are scored individually rather than pooled into a single ocular symptom score. Furthermore, the practice of allowing rescue medications likewise may preclude the ability to detect statistically significant differences in allergic eye symptoms between intranasal corticosteroids and controls. Recent data show a promising effect of intranasal corticosteroids on ocular symptoms of allergic rhinoconjunctivitis. Additional trials should be conducted that require individuals to score ocular symptoms individually and forbid the use of rescue medications.Keywords
This publication has 109 references indexed in Scilit:
- Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptomsAnnals of Allergy, Asthma & Immunology, 2006
- Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Increased Nasal Airflow With Budesonide Compared With Desloratadine During the Allergy SeasonJAMA Otolaryngology–Head & Neck Surgery, 2005
- Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukastAnnals of Allergy, Asthma & Immunology, 2003
- Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysisAnnals of Allergy, Asthma & Immunology, 2002
- Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2002
- Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of lifeAnnals of Allergy, Asthma & Immunology, 2000
- Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Clinical and Antiinflammatory Effects of Intranasal Budesonide Aqueous Pump Spray in the Treatment of Perennial Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1998